Mishka Terplan, M.D., M.P.H., FACOG, DFASAM

Mishka Terplan, M.D., M.P.H., FACOG, DFASAM
Mishka Terplan, M.D., M.P.H., FACOG, DFASAM
Medical Director/Senior Research Scientist

M.D., University of California, San Francisco
M.P.H., University of North Carolina, Chapel Hill
Phone: 410-837-3977 ext. 240
Fax: 410-752-4218
Research Interests

Dr. Mishka Terplan is board certified in both obstetrics and gynecology and in addiction medicine. His primary clinical, research and advocacy interests lie along the intersections of reproductive and behavioral health. Dr. Terplan is nationally recognized as an expert in the care of pregnant and parenting people with substance use disorder. He has been central to guidance document development at the American Congress of Obstetrician Gynecologists (ACOG), the American Society of Addiction Medicine (ASAM) and the Substance Abuse and Mental Health Services Administration (SAMHSA) and has participated in expert panels at Center for Disease Control, Office of the National Drug Control Policy, Office of Women’s Health, US Food and Drug Administration and the National Institutes of Health primarily on issues related to gender and addiction. Dr. Terplan has active grant funding and has published over 100 peer-reviewed articles with emphasis on addiction medicine, drug use in pregnancy, health disparities, stigma, and access to treatment.

In addition to his work for FRI, he is the Addiction Medicine Consultant for Virginia Medicaid and adjunct faculty at the University of California, San Francisco where he is a Substance Use Warmline clinician for its Clinical Consultation Center.

Selected Publications

Martin CE, Scialli A, Terplan M (in press). Unmet Substance Use Disorder Treatment Need among Reproductive Aged Women. Drug and Alcohol Dependence.

Ko J, Tong V, Haight S, Terplan M, Snead C, Shulkin J (in press). Obstetrician-Gynecologists’ practice patterns related to opioid use during pregnancy and postpartum – United States, 2017. Journal of Perinatology.

Ko J, Tong V, Haight S, Terplan M, Stark L, Snead C, Schulkin J (in press). Obstetrician-gynecologists’ practices and attitudes on substance use screening during pregnancy. Journal of Perinatology.

Ecker J, Abuhamad A, Hill W, Bailit J, Bateman BT, Berghella V, Blake-Lamb T, Guille C, Landau R, Minkoff H, Prabhu M, Rosenthal E, Terplan M, Wright TE, Yonkers KA (2019). Substance Use Disorders in Pregnancy: Clinical, Ethical, and Research Imperatives of the Opioid Epidemic: A report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine. American Journal of Obstetrics and Gynecology. 221(1):B5-B28. doi: 10.1016/j.ajog.2019.03.022. Epub 2019 Mar 27. PMID: 30928567.

Krans EE, Campopiano M, Cleveland LM, Goodman D, Kilday D, Kendig S, Leffert LR, Main EK, Mitchell KT, O’Gurek DT, D’Oria R, McDaniel D, Terplan M (2019). National Partnership for Maternal Safety: Consensus Bundle on Obstetric Care for Women with Opioid Use Disorder. Obstetrics & Gynecology. 134(2):365-375.

Larson JJ, Graham DL, Singer LT, Beckwith AM, Terplan M, Davis JM, Martinez J, Bada HS (2019). Cognitive and Behavioral Impact on Children Exposed to Opioids During Pregnancy. Pediatrics. 144(2). pii: e20190514. doi: 10.1542/peds.2019-0514. Epub 2019 Jul 18. PMID: 31320466.

MacAfee LK, Dalton V, Terplan M (2019). Pregnancy Intention, Risk Perception and Contraceptive Use In Pregnant Women Who Use Drugs. Journal of Addiction Medicine. 13(3):177-181. doi: 10.1097/ADM.0000000000000471. PMID: 30394994.

Martin CE, Terplan M, Krans EE (2019). Pain, Opioids and Pregnancy: Historical Context and Medical Management. Clin Perinatol. 46(4):833-847. doi: 10.1016/j.clp.2019.08.013. Epub 2019 Aug 22. PMID: 31653311.

Premkumar A, Grobman WA, Terplan M, Miller ES (2019). Methadone, buprenorphine, or detoxification for management of perinatal opioid use disorder: a cost-effectiveness analysis. Obstetrics & Gynecology. 134(5):921-931. doi: 10.1097/AOG.0000000000003503. PMID: 31599845.

Martin CE, Terplan M, O’Grady KE, Jones HE (2018). Brief Report: Pregnancy intention and opioid use disorder treatment retention in the MOTHER study. The American Journal on Addictions. doi: 10.1111/ajad.12735. [Epub ahead of print].

Schiff DM, Nielson T, Terplan M, Hood M, Bernson D, Diop H, Bharel M, Wilens TE, LaRochelle M, Walley A, Land T (2018). Fatal and Non-Fatal Opioid Overdose Among Pregnant and Postpartum Women in Massachusetts. Obstetrics & Gynecology. 132(2):466-474. doi: 10.1097/AOG.0000000000002734. PMID: 29995730 PMCID: PMC6060005.

Short VL, Hand DJ, MacAffee L, Abatemarco DJ, Terplan M (2018). Trends and disparities in receipt of pharmacotherapy among pregnant women in publicly funded treatment programs for opioid use disorder in the United States. Journal of Substance Abuse Treatment. 89:67-74. doi: 10.1016/j.jsat.2018.04.003. Epub 2018 Apr 6. PMID: 29706175.

Terplan M, Martin CE, Nail J, Sherman SG (2018). Contraceptive utilization among new exotic dancers: A cross sectional study. Harm Reduction Journal. 15(1):56. doi: 10.1186/s12954-018-0261-7. PMID: 30419913 PMCID: PMC6233581.

Terplan M, Laird HJ, Hand DJ, Wright TE, Premkumar A, Martin CE, Meyer MC, Jones HE, Krans EE (2018). Opioid Detoxification During Pregnancy: A Systematic Review. Obstetrics & Gynecology. 131(5):803-814. doi: 10.1097/AOG.0000000000002562. PMID: 29630016 PMCID: PMC6034119.

Mark K, Gryczynski J, Axenfeld E, Schwartz RP, Terplan M (2017). Pregnant Women’s Current and Intended Cannabis Use in Relation to Their Views Toward Legalization and Knowledge of Potential Harm. Journal of Addiction Medicine. 11(3):211-216. doi: 10.1097/ADM.0000000000000299. PMID: 28252456.

Mark K, Terplan M (2017). Cannabis and Pregnancy: Maternal Child Health Implications During a Period of Drug Policy Liberalization. Preventive Medicine. 7435(17)30175-5.

Terplan M (2017). Women and the opioid crisis: historical context and public health solutions. Fertility and Sterility. 108(2):195-199. doi: 10.1016/j.fertnstert.2017.06.007. Epub 2017 Jul 8. PMID: 28697909.

Terplan M, Minkoff H (2017). Neonatal Abstinence Syndrome and Ethical Approaches to the Identification of Pregnant Women Who Use Drugs. Obstetrics & Gynecology. 129(1):164-167. doi: 10.1097/AOG.0000000000001781. PMID: 27926654.

Mark K, Desai A, Terplan M (2016). Marijuana use and pregnancy: prevalence, associated characteristics, and birth outcomes. Archives of Women’s Mental Health. 19(1):105-11. doi: 10.1007/s00737-015-0529-9. Epub 2015 Apr 19. PMID: 25895138.

Robinowitz N, Schleibler J, Muqueeth S, Welsh C, Terplan M, Dineen R, O’Keefe G, Salisbury-Afshar E (2016). Family planning in substance use disorder treatment centers: Opportunities and Challenges. Substance Use and Misuse. 51(11):1477-83.

Wright TE, Terplan M, Ondersma SJ, Boyce C, Yonkers K, Chang G, Creanga AA (2016). The role of screening, brief intervention, and referral to treatment (SBIRT) in the perinatal period. American Journal of Obstetrics and Gynecology. 215(5):539-547. doi: 10.1016/j.ajog.2016.06.038. Epub 2016 Jul 1. PMID: 27373599.

Martin CE, Longinaker N, Terplan M (2015). Recent trends in treatment admissions for prescription opioid abuse during pregnancy. Journal of Substance Abuse Treatment. 48(1):37-42. doi: 10.1016/j.jsat.2014.07.007. Epub 2014 Jul 23. PMID: 25151440 PMCID: PMC4648237.

Terplan M, Hand DJ, Hutchinson M, Salisbury-Afshar E, Heil SH (2015). Contraceptive use and method choice among women with opioid and other substance use disorders: A systematic Review. Preventive Medicine. 80: 21-31. doi: 10.1016/j.ypmed.2015.04.008. Epub 2015 Apr 18. PMID: 25900803 PMCID: PMC4842019.

Terplan M, Kennedy-Hendricks A, Chisolm MS (2015). Prenatal substance use: Exploring assumptions of maternal unfitness. Substance Abuse: Research and Treatment. 9(S2):1-4. doi: 10.4137/SART.S23328. PMID: 26448685; PMCID: PMC4578572.

Terplan M, Longinaker N, Appel L (2015). Availability of women-centered drug treatment services in the United States, 2002-2009. American Journal of Public Health. 105(11): e50-e54. doi: 10.2105/AJPH.2015.302821. Epub 2015 Sep 17. PMID: 26378825 PMCID: PMC4605167.

Terplan M, Ramanadhan S, Locke A, Longinaker N, Lui S (2015). Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions. Cochrane Database of Systematic Reviews. (4):CD006037. doi: 10.1002/14651858.CD006037.pub3. PMID: 25835053; PMCID: PMC4894519.

Martin CE, Han JJ, Serio-Chapman C, Chaulk P, Terplan M (2014). Injectable contraceptive continuation among female exotic dancers seeking mobile reproductive health services. Journal of Health Care for the Poor and Underserved. 25(3):1317-27. doi: 10.1353/hpu.2014.0134. PMID: 25130242.

Terplan M, Smith EJ, Temkin S (2009). Racial Disparities in Ovarian Cancer Treatment and Outcomes: A systematic review. Cancer Causes and Control. 20(7):1139.